Condensed Consolidated Balance Sheets - USD ($) $ in Thousands	Jun. 30, 2024	Dec. 31, 2023
Current assets
Cash and cash equivalents	$ 128,211	$ 218,097
Short-term marketable securities	507,029	503,229
Prepaid expenses and other current assets	13,021	15,312
Total current assets	648,261	736,638
Prepaid expenses and other assets, non-current	325	2,678
Operating lease right-of-use asset	1,101	1,195
Property, plant and equipment, net	1,509	2,179
Restricted cash	543	0
Total assets	651,739	742,690
Current liabilities
Accounts payable	40,722	41,920
Accrued research and development expenses	35,117	35,436
Accrued compensation and other current liabilities	5,479	6,833
Severance liability	1,134	970
Total current liabilities	82,452	85,159
Operating lease liability, non-current	1,069	1,194
Total liabilities	83,521	86,353
Stockholders’ equity
Common stock, par value of $0.00001 per share; 790,000,000 shares authorized as of June 30, 2024 and December 31, 2023; 99,570,421 and 97,865,890 shares issued and outstanding as of June 30, 2024 and December 31, 2023, respectively	1	1
Additional paid-in capital	1,177,748	1,144,893
Accumulated other comprehensive income (loss)	(167)	162
Accumulated deficit	(609,364)	(488,719)
Total stockholders' equity	568,218	656,337
Total liabilities, redeemable convertible preferred stock and stockholders’ equity	$ 651,739	$ 742,690